Learn more

Jiangsu hengrui medicine co ltd

Overview
  • Total Patents
    333
  • GoodIP Patent Rank
    4,750
  • Filing trend
    ⇧ 101.0%
About

Jiangsu hengrui medicine co ltd has a total of 333 patent applications. It increased the IP activity by 101.0%. Its first patent ever was published in 2008. It filed its patents most often in Taiwan, Australia and Serbia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are JIANGSU HENGRUI MEDICINE CO, H LUNDBECK A and ACAD OF MILITARY MEDICAL SCIENCES.

Patent filings in countries

World map showing Jiangsu hengrui medicine co ltds patent filings in countries
# Country Total Patents
#1 Taiwan 198
#2 Australia 128
#3 Serbia 7

Patent filings per year

Chart showing Jiangsu hengrui medicine co ltds patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 He Feng 60
#2 Tao Wei-Kang 58
#3 Tao Weikang 39
#4 Zhang Lianshan 37
#5 Sun Piaoyang 32
#6 Zhang Lian-Shan 32
#7 Wu Guaili 22
#8 Liu Xun 19
#9 Feng Jun 19
#10 Hu Qiyue 19

Latest patents

Publication Filing date Title
TW202039582A Anti-epcam antibody and use thereof
TW202102204A Pharmaceutical composition comprising anti-il-5 antibody and uses thereof
TW202102505A A pyrroloheterocyclic derivative and preparation method and medical use thereof
TW202100150A Application of multi-target tyrosine kinase inhibitor combined with egfr inhibitor in preparing medicine for treating tumor
TW202102480A 6-oxo-1,6-dihydropyridazine prodrug derivative, preparation method therefor, and medical applications thereof
TW202045493A 2-aminopyrimidine derivatives, a preparation method thereof and a medical use thereof
TW202045538A Anti-pd-1 antibody, antigen-binding fragment thereof and pharmaceutical use thereof
TW202043233A Crystal forms of 1,2,3-triazolo [1,5-a] pyrazine derivatives and manufacturing method thereof
TW202043200A 2-oxo-1,2-dihydropyridin derivative, a preparation method thereof and a medical use thereof
TW202043197A Crystal form of indole formamide derivative and preparation method thereof
TW202024134A A bispecific protein
TW202034945A Human interleukin 2 variant or derivatives thereof
TW202034925A Use of cdk4/6 inhibitor in combination with immunotherapy for preparation of medicament for treating lymphoma
TW202021987A Cd3 antibody and its pharmaceutical use thereof
TW202039558A Anti-cd40 antibody, antigen-binding fragments and pharmaceutical use thereof
TW202039001A Use of anti-pd-1 antibody in combination with famitinib for preparation of medicament for treating tumor diseases
TW202014423A Indole macrocyclic derivatives, a preparation method thereof and medical use thereof
TW202027787A Use of ezh2 inhibitor in combination with immune checkpoint inhibitor for preparation of medicament for treating tumor diseases
AU2019351427A1 Anti-B7H3 antibody-exatecan analog conjugate and medicinal use thereof
AU2019347934A1 An anti-OX40 antibody, antigen-binding fragment thereof, and the pharmaceutical use